Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
Moman Aladdin MohammadSasha KoulGöran K OlivecronaMatthias GӧtbergPatrik TydénErik RydbergFredrik SchersténJoakim AlfredssonPeter VaskoElmir OmerovicOskar AngeråsOle FröbertFredrik CalaisSebastian VölzAnders UlvenstamDimitrios VenetsanosTroels YndigegnJonas OldgrenGiovanna SarnoPer GrimfjärdJonas PerssonNils WittEllen OstenfeldBertil LindahlStefan K JamesDavid ErlingePublished in: Heart (British Cardiac Society) (2020)
The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in overall short-term case fatality or quality of care indicators were observed.
Keyphrases
- percutaneous coronary intervention
- risk factors
- quality improvement
- healthcare
- heart failure
- acute coronary syndrome
- acute myocardial infarction
- palliative care
- st segment elevation myocardial infarction
- coronary artery disease
- left ventricular
- antiplatelet therapy
- coronary artery bypass grafting
- pain management
- atrial fibrillation
- chronic pain